Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 12;12(11):2666.
doi: 10.3390/polym12112666.

Hydroxypropyl Methylcellulose E15: A Hydrophilic Polymer for Fabrication of Orodispersible Film Using Syringe Extrusion 3D Printer

Affiliations

Hydroxypropyl Methylcellulose E15: A Hydrophilic Polymer for Fabrication of Orodispersible Film Using Syringe Extrusion 3D Printer

Pattaraporn Panraksa et al. Polymers (Basel). .

Abstract

Extrusion-based 3D printing technology is a relatively new technique that has a potential for fabricating pharmaceutical products in various dosage forms. It offers many advantages over conventional manufacturing methods, including more accurate drug dosing, which is especially important for the drugs that require exact tailoring (e.g., narrow therapeutic index drugs). In this work, we have successfully fabricated phenytoin-loaded orodispersible films (ODFs) through a syringe extrusion 3D printing technique. Two different grades of hydroxypropyl methylcellulose (HPMC E5 and HPMC E15) were used as the film-forming polymers, and glycerin and propylene glycol were used as plasticizers. The 3D-printed ODFs were physicochemically characterized and evaluated for their mechanical properties and in vitro disintegration time. Then, the optimum printed ODFs showing good mechanical properties and the fastest disintegration time were selected to evaluate their drug content and dissolution profiles. The results showed that phenytoin-loaded E15 ODFs demonstrated superior properties when compared to E5 films. It demonstrated a fast disintegration time in less than 5 s and rapidly dissolved and reached up to 80% of drug release within 10 min. In addition, it also exhibited drug content uniformity within United States Pharmacopeia (USP) acceptable range and exhibited good mechanical properties and flexibility with low puncture strength, low Young's modulus and high elongation, which allows ease of handling and application. Furthermore, the HPMC E15 printing dispersions with suitable concentrations at 10% w/v exhibited a non-Newtonian (shear-thinning) pseudoplastic behavior along with good extrudability characteristics through the extrusion nozzle. Thus, HPMC E15 can be applied as a 3D printing polymer for a syringe extrusion 3D printer.

Keywords: 3D printing; hydroxypropyl methylcellulose; orodispersible film; phenytoin; syringe extrusion 3D printing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic diagram of syringe extrusion 3D printer.
Figure 2
Figure 2
Computer-aided design (CAD) of the 3D-printed orodispersible films (ODF) (length 32.50 mm, width 32.50 mm and height 0.19 mm).
Figure 3
Figure 3
Rheological behaviors of hydroxypropyl methylcellulose (HPMC) E5 and HPMC E15 at different concentrations: (a) stress versus shear rate; (b) viscosity versus shear rate and fitting power-law model.
Figure 4
Figure 4
Scanning electron microscopy images of E15 (a), E15-PT (b), E15-PT-PG (c) and E15-PT-G (d).
Figure 5
Figure 5
In vitro phenytoin release from E15-PT, E15-PT-G and E15-PT-PG 3D-printed ODFs (n = 3) in Tris with 1% w/v SLS buffer solution (pH 6.8).

References

    1. Redekop W.K., Mladsi D. The Faces of Personalized Medicine: A Framework for Understanding Its Meaning and Scope. Value Health. 2013;16:S4–S9. doi: 10.1016/j.jval.2013.06.005. - DOI - PubMed
    1. Goole J., Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int. J. Pharm. 2016;499:376–394. doi: 10.1016/j.ijpharm.2015.12.071. - DOI - PubMed
    1. Cerda J.R., Arifi T., Ayyoubi S., Knief P., Ballesteros M.P., Keeble W., Barbu E., Healy A.M., Lalatsa A., Serrano D.R. Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms. Pharmaceutics. 2020;12:345. doi: 10.3390/pharmaceutics12040345. - DOI - PMC - PubMed
    1. Jamróz W., Szafraniec J., Kurek M., Jachowicz R. 3D Printing in Pharmaceutical and Medical Applications—Recent Achievements and Challenges. Pharm. Res. 2018;35:176. doi: 10.1007/s11095-018-2454-x. - DOI - PMC - PubMed
    1. Hoffmann E.M., Breitenbach A., Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin. Drug Deliv. 2011;8:299–316. doi: 10.1517/17425247.2011.553217. - DOI - PubMed

LinkOut - more resources